SkinMedica(R) Empowers Clear Skin Confidence with a New, Modern Approach to Acne PR Newswire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on ABBV
    AbbVie to Host First-Quarter 2024 Earnings Conference Call
    8:00a ET April 4 '24 PR Newswire

    AbbVie (NYSE: ABBV) will announce its first-quarter 2024 financial results on Friday, April 26, 2024, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

    About AbbVie

    AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas - immunology, oncology, neuroscience, and eye care - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

    https://mma.prnewswire.com/media/386913/AbbVie_logo.jpg

    https://c212.net/c/img/favicon.png?sn=CG78098&sd=2024-04-04

    View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-host-first-quarter-2024-earnings-conference-call-302107732.html

    SOURCE AbbVie

    https://rt.newswire.ca/rt.gif?NewsItemId=CG78098&Transmission_Id=202404040800PR_NEWS_USPR_____CG78098&DateId=20240404

    COMTEX_450321824/1005/2024-04-04T08:00:27

    SHAREHOLDER ALERT: Weiss Law Investigates Landos Biopharma, Inc.
    4:01p ET April 4 '24 ACCESSWIRE
    AbbVie to Host First-Quarter 2024 Earnings Conference Call
    8:00a ET April 4 '24 PR Newswire
    Allergan Aesthetics Announces the Return of CoolMonth with CoolSculpt...
    8:30a ET April 3 '24 PR Newswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Follow...
    11:51a ET April 1 '24 GlobeNewswire
    NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of...
    7:50a ET April 1 '24 GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Follow...
    11:10a ET March 25 '24 GlobeNewswire
    Allergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate...
    11:00a ET March 25 '24 PR Newswire
    AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfol...
    8:31a ET March 25 '24 PR Newswire
    AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfol...
    8:30a ET March 25 '24 GlobeNewswire
    U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAH...
    3:03p ET March 22 '24 PR Newswire

    Market data provided by News provided by